glp-1 pediatric GLP‐1 Agonists for Psychopharmacology: Opportunities and Cautions Prescribing GLP-1 to an overweight

Injectable GLP-1s have been studied in large human trials with clear dosing, safety monitoring, and proven effects on appetite and weightevidence that patches currently lack

Payers should also consider the range of coverage expansion options available that best optimize the cost to plan sponsors while providing members access to these revolutionary GLP-1 drugs

HARMONY 3: 104-Week Randomized, Double-Blind, Placebo- and Active-Controlled Trial Assessing the Efficacy and Safety of Albiglutide Compared With Placebo, Sitagliptin, and Glimepiride in Patients With Type 2 Diabetes Taking Metformin

T., Haavik, J., Klungsyr, K., & Engeland, A